Dry powder oligonucleotide formualtion, preparation and its uses
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
May 13, 2004
app pub date -
Jun 18, 2003
filing date -
Jun 18, 2002
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
A formulation consisting essentially of an oligo(s) and bearing greater than about 90% particles about 0.1.mu. to about 1.mu., or about 10.mu. to about 50.mu. in diameter. A dry powder formulation consisting essentially of an oligo of particle size about 0.1.mu. to about 100.mu. micron in diameter. Methods of preparation and therapeutic and diagnostic use are disclosed. Kits for diagnosis or treatment of numerous diseases and conditions by administration into the respiratory tract.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully